Skip to content

Clinical trials

Phase 2 Mesothelioma, Malignant trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 2 Country / region: Belgium Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20091
20132
20151
20161
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Cancer Trials Ireland1
European Lung Cancer Working Party1
Jules Bordet Institute1
MedImmune LLC1
NovoCure Ltd.1
University Hospital, Ghent1
Verastem, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant10
Breast Neoplasms1
Carcinoma, Hepatocellular1
Carcinoma, Merkel Cell1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Gastrointestinal Neoplasms1
Head and Neck Neoplasms1
Melanoma1
Mesothelioma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.